US District Court for the District of New Jersey Intellectual Property Cases

Patent - Abbreviated New Drug Application Cases, Dockets and Filings
Cases filed
Cases 51 - 60 of 769
CELGENE CORPORATION v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al
as 2:2024cv00500
Plaintiff: CELGENE CORPORATION
Defendant: AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, AMNEAL EU, LIMITED and AMNEAL PHARMACEUTICALS LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
HERON THERAPEUTICS, INC. v. SLAYBACK PHARMA LLC et al
as 2:2024cv00423
Plaintiff: HERON THERAPEUTICS, INC.
Defendant: SLAYBACK PHARMA LLC and SLAYBACK PHARMA INDIA LLP
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GALDERMA LABORATORIES, L.P. et al v. TARO PHARMACEUTICALS INC. et al
as 2:2024cv00333
Plaintiff: GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA RESEARCH & DEVELOPMENT, S.N.C. and others
Defendant: TARO PHARMACEUTICALS INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS U.S.A., INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GALDERMA LABORATORIES, L.P. et al v. TARO PHARMACEUTICALS INC. et al
as 3:2024cv00333
Plaintiff: GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA RESEARCH & DEVELOPMENT, S.N.C. and others
Defendant: TARO PHARMACEUTICALS INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS U.S.A., INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NOVO NORDISK INC. et al v. RIO BIOPHARMACEUTICALS, INC.
as 1:2024cv00330
Plaintiff: NOVO NORDISK INC. and NOVO NORDISK A/S
Defendant: RIO BIOPHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AXSOME MALTA LTD. et al v. AUROBINDO PHARMA USA, INC. et al
as 2:2024cv00309
Plaintiff: AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant: AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GALDERMA LABORATORIES, L.P. et al v. TEVA PHARMACEUTICALS, INC. et al
as 2:2024cv00197
Plaintiff: GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA RESEARCH & DEVELOPMENT, S.N.C. and others
Defendant: TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS INTERNATIONAL GMBH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GALDERMA LABORATORIES, L.P. et al v. TEVA PHARMACEUTICALS, INC. et al
as 3:2024cv00197
Plaintiff: GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA RESEARCH & DEVELOPMENT, S.N.C. and others
Defendant: TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS INTERNATIONAL GMBH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AXSOME MALTA LTD. et al v. HETERO USA INC. et al
as 2:2024cv00196
Plaintiff: AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant: HETERO USA INC., HETERO LABS LIMITED UNIT-V and HETERO LABS LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2024cv00150
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?